I don't know what the biotech field is like to operate in. I get the feeling that it is cut throat and full of the dirtiest tricks imaginable. Neither do I know any of the board personally, but rightly or wrongly I'm prepared to wait for the results of the increased spending on advice in the corporate domain. I don't know what will turn up, but I trust that these guys will do their best.
As a speccy stock this company sure fits the bill for a rocky ride that's for sure. I don't expect all investors to have my perspective on the company. We all invested in our own ways for our own reasons. Any thoughts on the research? Do you think they have developed products at a reasonably budgeted level for such a small company or not?
Ann: Market and Technology Update, page-119
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $47.27K | 463.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 319942 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 86442 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |